Cite
Robinson GW, Kaste SC, Chemaitilly W, et al. Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor. Oncotarget. 2017;8(41):69295-69302doi: 10.18632/oncotarget.20619.
Robinson, G. W., Kaste, S. C., Chemaitilly, W., Bowers, D. C., Laughton, S., Smith, A., Gottardo, N. G., Partap, S., Bendel, A., Wright, K. D., Orr, B. A., Warner, W. C., Onar-Thomas, A., & Gajjar, A. (2017). Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor. Oncotarget, 8(41), 69295-69302. https://doi.org/10.18632/oncotarget.20619
Robinson, Giles W, et al. "Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor." Oncotarget vol. 8,41 (2017): 69295-69302. doi: https://doi.org/10.18632/oncotarget.20619
Robinson GW, Kaste SC, Chemaitilly W, Bowers DC, Laughton S, Smith A, Gottardo NG, Partap S, Bendel A, Wright KD, Orr BA, Warner WC, Onar-Thomas A, Gajjar A. Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor. Oncotarget. 2017 Sep 01;8(41):69295-69302. doi: 10.18632/oncotarget.20619. eCollection 2017 Sep 19. PMID: 29050204; PMCID: PMC5642479.
Copy
Download .nbib